000 01529 a2200409 4500
005 20250515085604.0
264 0 _c20080110
008 200801s 0 0 eng d
022 _a0171-2985
024 7 _a10.1016/j.imbio.2007.05.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAllam, Gamal
245 0 0 _aVasoactive intestinal peptide inhibits liver pathology in acute murine schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-alpha production.
_h[electronic resource]
260 _bImmunobiology
_c2007
300 _a603-12 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcute Disease
650 0 4 _aAlanine Transaminase
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAspartate Aminotransferases
_xmetabolism
650 0 4 _aInterleukin-10
_xblood
650 0 4 _aInterleukin-12
_xblood
650 0 4 _aLiver
_xenzymology
650 0 4 _aLiver Diseases, Parasitic
_xdrug therapy
650 0 4 _aLiver Extracts
_xmetabolism
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aSchistosoma mansoni
_xgrowth & development
650 0 4 _aSchistosomiasis mansoni
_xdrug therapy
650 0 4 _aSwine
650 0 4 _aTumor Necrosis Factor-alpha
_xbiosynthesis
650 0 4 _aVasoactive Intestinal Peptide
_xpharmacology
650 0 4 _aVasodilator Agents
_xpharmacology
650 0 4 _agamma-Glutamyltransferase
_xmetabolism
773 0 _tImmunobiology
_gvol. 212
_gno. 8
_gp. 603-12
856 4 0 _uhttps://doi.org/10.1016/j.imbio.2007.05.006
_zAvailable from publisher's website
999 _c17396831
_d17396831